Literature DB >> 21315999

Control of methicillin-resistant Staphylococcus aureus.

Andie S Lee1, Benedikt Huttner, Stephan Harbarth.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of nosocomial infections worldwide. Different approaches to the control of this pathogen have met with varying degrees of success in different health care settings. Controversies exist with regards to various MRSA control strategies. The implementation and outcomes of control measures depend on several factors, including scientific, economic, administrative, governmental, and political influences. It is clear that flexibility to adapt and institute these measures in the context of local epidemiology and resources is required.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21315999     DOI: 10.1016/j.idc.2010.11.002

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  18 in total

Review 1.  Gloves, gowns and masks for reducing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in the hospital setting.

Authors:  Jesús López-Alcalde; Marta Mateos-Mazón; Marcela Guevara; Lucieni O Conterno; Ivan Solà; Sheila Cabir Nunes; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2015-07-16

2.  A survey of methicillin-resistant Staphylococcus aureus control strategies in Italy.

Authors:  A Pan; E Bombana; G Tura; C Curti; S Lorenzotti; P Mondello; A Patroni; E Tacconelli; V Rigobello; L Signorini; M Vizio; A Goglio
Journal:  Infection       Date:  2013-04-01       Impact factor: 3.553

Review 3.  [Prevention of transmission of multidrug-resistant bacteria].

Authors:  R Fussen; S Lemmen
Journal:  Internist (Berl)       Date:  2015-11       Impact factor: 0.743

4.  Comparison of strategies to reduce meticillin-resistant Staphylococcus aureus rates in surgical patients: a controlled multicentre intervention trial.

Authors:  Andie S Lee; Ben S Cooper; Surbhi Malhotra-Kumar; Annie Chalfine; George L Daikos; Carolina Fankhauser; Biljana Carevic; Sebastian Lemmen; José Antonio Martínez; Cristina Masuet-Aumatell; Angelo Pan; Gabby Phillips; Bina Rubinovitch; Herman Goossens; Christian Brun-Buisson; Stephan Harbarth
Journal:  BMJ Open       Date:  2013-09-19       Impact factor: 2.692

Review 5.  Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.

Authors:  Aibek E Mirrakhimov
Journal:  Cardiovasc Diabetol       Date:  2012-10-27       Impact factor: 9.951

6.  Antibacterial activity of extracellular compounds produced by a Pseudomonas strain against methicillin-resistant Staphylococcus aureus (MRSA) strains.

Authors:  Viviane F Cardozo; Admilton G Oliveira; Erick K Nishio; Marcia R E Perugini; Célia G T J Andrade; Wanderley D Silveira; Nelson Durán; Galdino Andrade; Renata K T Kobayashi; Gerson Nakazato
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-06-17       Impact factor: 3.944

7.  Do active surveillance and contact precautions reduce MRSA acquisition? A prospective interrupted time series.

Authors:  Caroline Marshall; Michael Richards; Emma McBryde
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

8.  Impact of mupirocin resistance on the transmission and control of healthcare-associated MRSA.

Authors:  Sarah R Deeny; Colin J Worby; Olga Tosas Auguet; Ben S Cooper; Jonathan Edgeworth; Barry Cookson; Julie V Robotham
Journal:  J Antimicrob Chemother       Date:  2015-09-03       Impact factor: 5.790

9.  The dynamics of methicillin-resistant Staphylococcus aureus exposure in a hospital model and the potential for environmental intervention.

Authors:  Nottasorn Plipat; Ian H Spicknall; James S Koopman; Joseph Ns Eisenberg
Journal:  BMC Infect Dis       Date:  2013-12-17       Impact factor: 3.090

10.  A model-based analysis: what potential could there be for a S. aureus vaccine in a hospital setting on top of other preventative measures?

Authors:  Cosmina Hogea; Thierry Van Effelterre; Adrian Cassidy
Journal:  BMC Infect Dis       Date:  2014-05-28       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.